☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
App
Advertisement
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Bridge Biotherapeutics Reports P-IIa Clinical Trial Results of BBT-401 for the Treatment of Ulcerative Colitis
February 21, 2023
Top 20 Radiopharma Companies Based on Market Cap
February 21, 2023
Junshi Biosciences Reports P-III (TORCHLIGHT Study) Results of Toripalimab for Advanced Triple-Negative Breast Cancer
February 21, 2023
Travere Therapeutics’ Filspari (sparsentan) Receives the US FDA’s Accelerated Approval for the Reduction of Proteinuria in IgA Nep...
February 21, 2023
Apellis’ Syfovre Receives the US FDA’s Approval as the First Treatment for Geographic Atrophy
February 21, 2023
BMS Reports P-III Trial (CheckMate-274) Results of Opdivo (nivolumab) for High-Risk Muscle-Invasive Urothelial Carcinoma
February 21, 2023
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions